{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:18:41Z","timestamp":1768036721498,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:00:00Z","timestamp":1612656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jfma.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T20:43:59Z","timestamp":1614285839000},"page":"1611-1619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Altered sensory nerve excitability in fibromyalgia"],"prefix":"10.1016","volume":"120","author":[{"given":"Hao-Wen","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-6779","authenticated-orcid":false,"given":"Jowy","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsui-San","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy Shin-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ying","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.02.003_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jpain.2009.06.001","article-title":"Understanding fibromyalgia: lessons from the broader pain research community","volume":"10","author":"Williams","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.jfma.2021.02.003_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfma.2021.02.003_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jfma.2021.02.003_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jfma.2021.02.003_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jfma.2021.02.003_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jfma.2016.10.015","article-title":"Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: a cross-sectional study","volume":"116","author":"Lin","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2021.02.003_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0929-6646(11)60074-0","article-title":"Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance","volume":"110","author":"Wen","year":"2011","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.jfma.2021.02.003_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pec.2008.06.005","article-title":"Patient perspectives on the impact of fibromyalgia","volume":"73","author":"Arnold","year":"2008","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jfma.2021.02.003_bib9","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","article-title":"Characteristics and healthcare costs of patients with fibromyalgia syndrome","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.jfma.2021.02.003_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4065\/74.4.385","article-title":"Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia","volume":"74","author":"Bennett","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jfma.2021.02.003_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","article-title":"Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia","volume":"46","author":"Gracely","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfma.2021.02.003_bib12","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jfma.2021.02.003_bib13","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/art.38662","article-title":"Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications","volume":"66","author":"Caro","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.jfma.2021.02.003_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00415-013-7211-9","article-title":"Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features","volume":"261","author":"de Tommaso","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.jfma.2021.02.003_bib15","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/j.pain.0000000000000285","article-title":"Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia","volume":"156","author":"Doppler","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jfma.2021.02.003_bib16","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jfma.2021.02.003_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ana.24065","article-title":"Hyperexcitable C nociceptors in fibromyalgia","volume":"75","author":"Serra","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfma.2021.02.003_bib18","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jfma.2021.02.003_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1570159X113119990042","article-title":"Potassium channels in peripheral pain pathways: expression, function and therapeutic potential","volume":"11","author":"Du","year":"2013","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"10.1016\/j.jfma.2021.02.003_bib20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2021.02.003_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tins.2013.12.002","article-title":"Opening paths to novel analgesics: the role of potassium channels in chronic pain","volume":"37","author":"Tsantoulas","year":"2014","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jfma.2021.02.003_bib22","series-title":"Aminoff's electrodiagnosis in clinical neurology","first-page":"345","article-title":"Nerve excitability: a clinical translation","author":"Kiernan","year":"2012"},{"issue":"1","key":"10.1016\/j.jfma.2021.02.003_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clinph.2019.07.023","article-title":"Measurement of axonal excitability: Consensus guidelines","volume":"131","author":"Kiernan","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jfma.2021.02.003_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia\u00a0diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jfma.2021.02.003_bib25","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","article-title":"The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties","volume":"11","author":"Bennett","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jfma.2021.02.003_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/mus.1085","article-title":"Clinical evaluation of excitability measures in sensory nerve","volume":"24","author":"Kiernan","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jfma.2021.02.003_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G","article-title":"Multiple measures of axonal excitability: a new approach in clinical testing","volume":"23","author":"Kiernan","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jfma.2021.02.003_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1113\/jphysiol.1987.sp016395","article-title":"Function and distribution of three types of rectifying channel in rat spinal root myelinated axons","volume":"383","author":"Baker","year":"1987","journal-title":"J Physiol"},{"key":"10.1016\/j.jfma.2021.02.003_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-8993(88)90564-1","article-title":"Evidence for two types of potassium channel in human motor axons in\u00a0vivo","volume":"462","author":"Bostock","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.jfma.2021.02.003_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-444-52902-2.00004-7","article-title":"Physiology and pathophysiology of myelinated nerve fibers","volume":"115","author":"Kiernan","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jfma.2021.02.003_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2006.06.092","article-title":"MEMFIT: a computer program to aid interpretation of multiple excitability measurements on human motor axons","volume":"117","author":"Bostock","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jfma.2021.02.003_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.1982.sp014064","article-title":"Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential","volume":"323","author":"Barrett","year":"1982","journal-title":"J Physiol"},{"key":"10.1016\/j.jfma.2021.02.003_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171223","article-title":"Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy","volume":"12","author":"Sung","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2021.02.003_bib34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp-2014-308088","article-title":"Sensory axonal dysfunction in cervical radiculopathy","volume":"86","author":"Sung","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jfma.2021.02.003_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1113\/jphysiol.1995.sp021037","article-title":"Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons","volume":"489","author":"David","year":"1995","journal-title":"J Physiol"},{"key":"10.1016\/j.jfma.2021.02.003_bib36","series-title":"Handbook of clinical neurophysiology","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1567-4231(09)70078-4","article-title":"Assessment of nerve excitability properties in peripheral nerve disease","author":"Lin","year":"2006"},{"key":"10.1016\/j.jfma.2021.02.003_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.70.1.56","article-title":"Excitability properties of motor axons in patients with spontaneous motor unit activity","volume":"70","author":"Kiernan","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jfma.2021.02.003_bib38","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/brain\/awq318","article-title":"Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1","volume":"133","author":"Tomlinson","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jfma.2021.02.003_bib39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/jdi.13151","article-title":"Early sensory neurophysiological changes in prediabetes","volume":"11","author":"Lin","year":"2020","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jfma.2021.02.003_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1874467210801010061","article-title":"Pharmacologic intervention in axonal excitability: in\u00a0vivo assessment of nodal persistent sodium currents in human neuropathies","volume":"1","author":"Kuwabara","year":"2008","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.jfma.2021.02.003_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0022-510X(83)90145-4","article-title":"Effects of 4-aminopyridine in patients with multiple sclerosis","volume":"60","author":"Jones","year":"1983","journal-title":"J Neurol Sci"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:44:35Z","timestamp":1760539475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0929664621000607"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.02.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered sensory nerve excitability in fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}